Advisor Group’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$144K Sell
4,008
-47
-1% -$1.62K ﹤0.01% 2655
2019
Q3
$138K Buy
4,055
+2,148
+113% +$68.6K ﹤0.01% 2638
2019
Q2
$53K Sell
1,907
-269
-12% -$7.47K ﹤0.01% 3319
2019
Q1
$68K Buy
2,176
+1,097
+102% +$29.3K ﹤0.01% 3162
2018
Q4
$25K Sell
1,079
-72
-6% -$1.97K ﹤0.01% 3658
2018
Q3
$45K Buy
1,151
+340
+42% +$12.3K ﹤0.01% 3375
2018
Q2
$27K Sell
811
-2,711
-77% -$96.4K ﹤0.01% 3524
2018
Q1
$128K Sell
3,522
-3,511
-50% -$122K ﹤0.01% 2346
2017
Q4
$223K Buy
7,033
+1,550
+28% +$53.1K ﹤0.01% 1902
2017
Q3
$205K Buy
5,483
+2,980
+119% +$101K ﹤0.01% 1834
2017
Q2
$79K Sell
2,503
-233
-9% -$6.73K ﹤0.01% 2499
2017
Q1
$67K Buy
2,736
+2,316
+551% +$54.4K ﹤0.01% 2478
2016
Q4
$10K Buy
420
+323
+333% +$7.17K ﹤0.01% 3624
2016
Q3
$2K Buy
+97
New +$1.7K ﹤0.01% 4170

Other funds holding LMAT

Advisor Group's LMAT Position: Q4 2019 in Review

Advisor Group reduced its LeMaitre Vascular (LMAT) stake by 1.2% in Q4 2019, selling an estimated $1.62K and leaving 4,008 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Advisor Group first reported a position in LMAT in Q3 2016 and has held it in 14 quarters since. The position peaked at $223K in Q4 2017. 165 funds tracked by Wall St. Rank hold LMAT as of Q4 2019.

  • Advisor Group held 4,008 shares of LeMaitre Vascular worth $144K as of Q4 2019.
  • Advisor Group sold 47 LeMaitre Vascular shares in Q4 2019, an estimated $1.62K.
  • LeMaitre Vascular made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2655 holding.
  • Advisor Group first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 14 quarters since.
  • Advisor Group's LeMaitre Vascular position peaked at $223K in Q4 2017.
  • 165 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.